CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-31 | Vieser Jaime Director | Sale | −2,182 | $2.01 | $4K | 26,712 |
| 2024-12-31 | Vieser Jaime Director | Sale | −818 | $2.00 | $2K | 25,894 |
| 2023-09-01 | Boyle Kevin S. Sr. Chief Executive Officer | Sale 10b5-1 | −68,014 | $0.14 | $10K | 798,236 |
| 2021-12-22 | De Groot Eleanor EVP, Operations | Sale | −20,132 | $1.27 | $26K | 237,106 |
| 2021-01-08 | Buck Jill EVP, GM Gene Therapy | Sale | −27,894 | $3.12 | $87K | 199,516 |
| 2021-01-08 | Lafond Kevin G SVP, Treasurer & CAO | Sale | −18,020 | $3.09 | $56K | 63,965 |
| 2021-01-08 | Hadfield Robert General Counsel and Secretary | Sale | −26,500 | $3.12 | $83K | 133,319 |
| 2021-01-04 | De Groot Eleanor EVP, GM Cell Therapy | Sale | −21,620 | $2.72 | $59K | 206,413 |
| 2021-01-04 | Cooper Laurence James Neil President and CEO | Sale | −105,693 | $2.71 | $286K | 1,799,280 |
| 2020-01-02 | MAUNEY DAVID M MD President | Sale | −22,394 | $4.55 | $102K | 195,278 |
| 2020-01-02 | Lafond Kevin G SVP, Treasurer & CAO | Sale | −21,570 | $4.55 | $98K | 63,985 |
| 2020-01-02 | Hadfield Robert General Counsel and Secretary | Sale | −16,853 | $4.55 | $77K | 100,719 |
| 2020-01-02 | De Groot Eleanor EVP, GM Cell Therapy | Sale | −24,890 | $4.55 | $113K | 174,333 |
| 2020-01-02 | Buck Jill EVP, GM Gene Therapy | Sale | −27,923 | $4.55 | $127K | 173,710 |
| 2019-12-30 | Cooper Laurence James Neil Chief Executive Officer | Sale | −110,694 | $4.88 | $540K | 1,733,273 |
| 2019-11-26 | Lafond Kevin G SVP, Treasurer & CAO | Sale | −11,667 | $5.25 | $61K | 85,555 |
Page 1 of 1 · 16 trades